Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pancreatic Cancer Detection Consortium
Sponsor: City of Hope Medical Center
Summary
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
Official title: Early Detection of Pancreatic Cancer: Prospective Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2023-03-15
Completion Date
2026-06-18
Last Updated
2025-12-19
Healthy Volunteers
Yes
Conditions
Interventions
PANcreatic cancer Exosome Early detectiON (PANXEON)
This test will utilize quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) to quantify the expression levels of 5 cell-free and 8 exosome-miRNAs in plasma samples obtained from patients with pancreatic ductal adenocarcinoma and from individuals without it
Locations (11)
Translational Genomics Research Institute
Phoenix, Arizona, United States
Honorhealth
Scottsdale, Arizona, United States
City of Hope Medical Center
Monrovia, California, United States
Hoag Center
Newport Beach, California, United States
OSF HealthCare
Peoria, Illinois, United States
Ochsner Medical Center
Jefferson, Louisiana, United States
Atlantic Health System
Morristown, New Jersey, United States
Piedmont Medical Center
Rock Hill, South Carolina, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Nagoya University
Nagoya, Japan
Asan Medical Center
Seoul, South Korea